Butalbital, Aspirin and Caffeine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceutical Corp. The primary component is Butalbital; Aspirin; Caffeine.
Product ID | 0143-1785_576e3e85-d465-4c0f-9d8a-3a786e2becd2 |
NDC | 0143-1785 |
Product Type | Human Prescription Drug |
Proprietary Name | Butalbital, Aspirin and Caffeine |
Generic Name | Butalbital, Aspirin And Caffeine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1979-06-05 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA086162 |
Labeler Name | West-ward Pharmaceutical Corp |
Substance Name | BUTALBITAL; ASPIRIN; CAFFEINE |
Active Ingredient Strength | 50 mg/1; mg/1; mg/1 |
Pharm Classes | Barbiturates [CS],Barbiturate [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE] |
DEA Schedule | CIII |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 1979-06-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA086162 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1979-06-05 |
Marketing End Date | 2016-09-30 |
Marketing Category | ANDA |
Application Number | ANDA086162 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1979-06-05 |
Marketing End Date | 2016-09-30 |
Marketing Category | ANDA |
Application Number | ANDA086162 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1979-06-05 |
Marketing End Date | 2016-09-30 |
Marketing Category | ANDA |
Application Number | ANDA086162 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1979-06-05 |
Marketing End Date | 2016-09-30 |
Marketing Category | ANDA |
Application Number | ANDA086162 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1979-06-05 |
Marketing End Date | 2016-09-30 |
Marketing Category | ANDA |
Application Number | ANDA086162 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1979-06-05 |
Marketing End Date | 2016-09-30 |
Ingredient | Strength |
---|---|
BUTALBITAL | 50 mg/1 |
SPL SET ID: | cae6b59d-13dc-49ea-ad4b-2f2bdae23840 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
Pharm Class PE | |
PHarm Class EPC | |
UPC Code | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0143-1785 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
21695-354 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
42543-098 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
52959-370 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
66336-619 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |